We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAB
2551
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
$490K ﹤0.01%
52,663
+125
+0.2% +$1.16K
LI icon
2552
Li Auto
LI
$12.7B
$490K ﹤0.01%
13,731
+45
+0.3% +$1.77K
GLRE icon
2553
Greenlight Captial
GLRE
$506M
$488K ﹤0.01%
45,417
+706
+2% +$7.6K
LUCK
2554
Lucky Strike Entertainment
LUCK
$911M
$487K ﹤0.01%
50,670
+77
+0.2% +$847
VITL icon
2555
Vital Farms
VITL
$525M
$487K ﹤0.01%
42,056
+212
+0.5% +$2.44K
LILA icon
2556
Liberty Latin America Class A
LILA
$1.67B
$487K ﹤0.01%
87,803
+1,218
+1% +$7.06K
DOMO icon
2557
Domo
DOMO
$184M
$487K ﹤0.01%
49,612
-3,848
-7% -$53.5K
PRME icon
2558
Prime Medicine
PRME
$559M
$486K ﹤0.01%
50,959
+3,896
+8% +$50.6K
ANIK icon
2559
Anika Therapeutics
ANIK
$287M
$485K ﹤0.01%
26,031
-25,682
-50% -$533K
TWKS
2560
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$483K ﹤0.01%
118,498
+2,158
+2% +$12.3K
MCBC
2561
DELISTED
Macatawa Bank Corp
MCBC
$482K ﹤0.01%
53,823
+14,213
+36% +$133K
LOGI icon
2562
Logitech
LOGI
$15.2B
$479K ﹤0.01%
6,948
TAL icon
2563
TAL Education Group
TAL
$6.87B
$479K ﹤0.01%
52,565
-3,889
-7% -$27.3K
SENEA icon
2564
Seneca Foods Class A
SENEA
$1.21B
$478K ﹤0.01%
8,874
-8,575
-49% -$384K
CHRS icon
2565
Coherus Oncology
CHRS
$196M
$477K ﹤0.01%
127,676
-93,411
-42% -$431K
ESQ icon
2566
Esquire Financial Holdings
ESQ
$1.14B
$477K ﹤0.01%
10,446
-34
-0.3% -$1.61K
ALPN
2567
DELISTED
Alpine Immune Sciences Inc
ALPN
$474K ﹤0.01%
41,403
+1,977
+5% +$24.3K
HTB
2568
HomeTrust Bancshares
HTB
$848M
$473K ﹤0.01%
21,844
+282
+1% +$6.49K
QSR icon
2569
Restaurant Brands International
QSR
$25.8B
$473K ﹤0.01%
7,102
+30
+0.4% +$2.15K
PTR
2570
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$473K ﹤0.01%
11,188
BZ icon
2571
Kanzhun
BZ
$7.36B
$472K ﹤0.01%
31,127
-5,367
-15% -$84.2K
MAXN
2572
DELISTED
Maxeon Solar Technologies
MAXN
$471K ﹤0.01%
407
+48
+13% +$91.2K
ENB icon
2573
Enbridge
ENB
$112B
$471K ﹤0.01%
14,201
+942
+7% +$33.4K
TKC icon
2574
Turkcell
TKC
$4.79B
$471K ﹤0.01%
99,579
+8,730
+10% +$41.6K
ELVN icon
2575
Enliven Therapeutics
ELVN
$4.43B
$469K ﹤0.01%
34,363
-433
-1% -$7.29K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.